Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland - PubMed

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland - PubMed

Prevalence of Recurrent Mutations Predisposing to Breast Cancer in Early-Onset Breast Cancer Patients from Poland

Emilia Rogoża-Janiszewska 1, Karolina Malińska 1, Cezary Cybulski 1, Anna Jakubowska 1, Jacek Gronwald 1, Tomasz Huzarski 1, Marcin Lener 1, Bohdan Górski 1, Wojciech Kluźniak 1, Helena Rudnicka 1, Mohammad R Akbari 2 3, Aniruddh Kashyap 1, Steven A Narod 2 3, Jan Lubiński 1, Tadeusz Dębniak 1, On Behalf Of The Polish Hereditary Breast Cancer Consortium

Affiliations 

• PMID: 32824581
 
• DOI: 10.3390/cancers12082321

Free article

Abstract

There are twenty recurrent mutations in six breast-cancer-predisposing genes in Poland (BRCA1, BRCA2, CHEK2, PALB2, NBN, and RECQL). The frequencies of the twenty alleles have not been measured in a large series of early-onset breast cancer patients from Poland unselected for family history. We genotyped 2464 women with breast cancer diagnosed below age 41 years for twenty recurrent germline mutations in six genes, including BRCA1, BRCA2 CHEK2, PALB2, NBN, and RECQL. A mutation in one of the six genes was identified in 419 of the 2464 early-onset breast cancer cases (17%), including 22.4% of those cases diagnosed below age 31. The mutation frequency was 18.8% for familial breast cancer cases and 6% for non-familial cases. Among women with breast cancer below age 31, the mutation frequency was 23.6% for familial cases and 17.4% in non-familial cases. The majority of mutations (76.2%) were seen in BRCA1 and BRCA2. In Poland, a panel of twenty recurrent mutations in six genes can identify a genetic basis for a high percentage of early-onset cases and testing is recommended for all women with breast cancer at age 40 or below.

Keywords: BRCA1; BRCA2; CHEK2; NBN; PALB2; RECQL; breast cancer; hereditary.

Similar articles

• The spectrum of mutations predisposing to familial breast cancer in Poland.

  Cybulski C, Kluźniak W, Huzarski T, Wokołorczyk D, Kashyap A, Rusak B, Stempa K, Gronwald J, Szymiczek A, Bagherzadeh M, Jakubowska A, Dębniak T, Lener M, Rudnicka H, Szwiec M, Jarkiewicz-Tretyn J, Stawicka M, Domagała P, Narod SA, Lubiński J, Akbari MR; Polish Hereditary Breast Cancer Consortium.Int J Cancer. 2019 Dec 15;145(12):3311-3320. doi: 10.1002/ijc.32492. Epub 2019 Jun 26.PMID: 31173646
• Selected Aspects of Molecular Diagnostics of Constitutional Alterations in BRCA1 and BRCA2 Genes Associated with Increased Risk of Breast Cancer in the Polish Population.

  Górski B.Hered Cancer Clin Pract. 2006 Aug 15;4(3):142-52. doi: 10.1186/1897-4287-4-3-142.PMID: 20223018 Free PMC article.
• Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.

  Cybulski C, Lubiński J, Wokołorczyk D, Kuźniak W, Kashyap A, Sopik V, Huzarski T, Gronwald J, Byrski T, Szwiec M, Jakubowska A, Górski B, Dębniak T, Narod SA, Akbari MR.Clin Genet. 2015 Oct;88(4):366-70. doi: 10.1111/cge.12524. Epub 2014 Nov 13.PMID: 25330149
• [The clinical importance of a genetic analysis of moderate-risk cancer susceptibility genes in breast and other cancer patients from the Czech Republic].

  Pohlreich P, Kleibl Z, Kleiblová P, Janatová M, Soukupová J, Macháčková E, Házová J, Vašíčková P, Sťahlová Hrabincová E, Navrátilová M, Svoboda M, Foretová L.Klin Onkol. 2012;25 Suppl:S59-66.PMID: 22920209 Review. Czech.
• Clinical implications of germline mutations in breast cancer genes: RECQL.

  Bowden AR, Tischkowitz M.Breast Cancer Res Treat. 2019 Apr;174(3):553-560. doi: 10.1007/s10549-018-05096-6. Epub 2019 Jan 4.PMID: 30610487 Free PMC article. Review.